155 related articles for article (PubMed ID: 17191217)
1. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2008 Jan; 28(1):39-117. PubMed ID: 17191217
[TBL] [Abstract][Full Text] [Related]
2. Review in quantitative structure activity relationships on lipoxygenase inhibitors.
Eleni P; Dimitra HL
Mini Rev Med Chem; 2003 Aug; 3(5):487-99. PubMed ID: 12769699
[TBL] [Abstract][Full Text] [Related]
3. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure activity relationship (QSAR) analysis of substituted 4-oxothiazolidines and 5-arylidines as lipoxygenase inhibitors.
Choudhary AN; Kumar A; Juyal V
Mini Rev Med Chem; 2010 Jul; 10(8):705-14. PubMed ID: 20412041
[TBL] [Abstract][Full Text] [Related]
5. Current trends in quantitative structure activity relationships on FXa inhibitors: evaluation and comparative analysis.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2004 Nov; 24(6):687-747. PubMed ID: 15250038
[TBL] [Abstract][Full Text] [Related]
6. Current trends in QSAR on NO donors and inhibitors of nitric oxide synthase (NOS)*.
Kontogiorgis CA; Hadjipavlou-Litina D
Med Res Rev; 2002 Jul; 22(4):385-418. PubMed ID: 12111751
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors.
Bakavoli M; Nikpour M; Rahimizadeh M; Saberi MR; Sadeghian H
Bioorg Med Chem; 2007 Mar; 15(5):2120-6. PubMed ID: 17210254
[TBL] [Abstract][Full Text] [Related]
8. Chalcones in cancer: understanding their role in terms of QSAR.
Katsori AM; Hadjipavlou-Litina D
Curr Med Chem; 2009; 16(9):1062-81. PubMed ID: 19275612
[TBL] [Abstract][Full Text] [Related]
9. Chalcones in cancer: understanding their role in terms of QSAR. II part.
Repanas A; Katsori AM; Hadjipavlou-Litina D
Mini Rev Med Chem; 2013 Jun; 13(7):952-70. PubMed ID: 22876949
[TBL] [Abstract][Full Text] [Related]
10. Structural biology of mammalian lipoxygenases: enzymatic consequences of targeted alterations of the protein structure.
Kuhn H; Saam J; Eibach S; Holzhütter HG; Ivanov I; Walther M
Biochem Biophys Res Commun; 2005 Dec; 338(1):93-101. PubMed ID: 16168952
[TBL] [Abstract][Full Text] [Related]
11. QSAR study for the soybean 15-lipoxygenase inhibitory activity of organosulfur compounds derived from the essential oil of garlic.
Camargo AB; Marchevsky E; Luco JM
J Agric Food Chem; 2007 Apr; 55(8):3096-103. PubMed ID: 17367159
[TBL] [Abstract][Full Text] [Related]
12. Overcoming tumor drug resistance with C2-modified 10-deacetyl-7-propionyl cephalomannines: a QSAR study.
Hansch C; Verma RP
Mol Pharm; 2009; 6(3):849-60. PubMed ID: 19334723
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase inhibitors (HDACIs). Structure--activity relationships: history and new QSAR perspectives.
Pontiki E; Hadjipavlou-Litina D
Med Res Rev; 2012 Jan; 32(1):1-165. PubMed ID: 20162725
[TBL] [Abstract][Full Text] [Related]
14. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
Payne AN; Jackson WP; Salmon JA; Nicholls A; Yeadon M; Garland LG
Agents Actions Suppl; 1991; 34():189-99. PubMed ID: 1793063
[TBL] [Abstract][Full Text] [Related]
15. Secondary alkyl hydroperoxides as inhibitors and alternate substrates for lipoxygenase.
Waller TM; Decker I; Frisch JP; Kernstock RM; Kim YW; Funk MO
Biochemistry; 2008 Jan; 47(1):331-8. PubMed ID: 18067328
[TBL] [Abstract][Full Text] [Related]
16. An Approach towards the quantitative structure-activity relationships of caffeic acid and its derivatives.
Verma RP; Hansch C
Chembiochem; 2004 Sep; 5(9):1188-95. PubMed ID: 15368569
[TBL] [Abstract][Full Text] [Related]
17. The novel ketoprofen amides--synthesis and biological evaluation as antioxidants, lipoxygenase inhibitors and cytostatic agents.
Rajić Z; Hadjipavlou-Litina D; Pontiki E; Kralj M; Suman L; Zorc B
Chem Biol Drug Des; 2010 Jun; 75(6):641-52. PubMed ID: 20337784
[TBL] [Abstract][Full Text] [Related]
18. Natural and synthetic 2'-hydroxy-chalcones and aurones: synthesis, characterization and evaluation of the antioxidant and soybean lipoxygenase inhibitory activity.
Detsi A; Majdalani M; Kontogiorgis CA; Hadjipavlou-Litina D; Kefalas P
Bioorg Med Chem; 2009 Dec; 17(23):8073-85. PubMed ID: 19853459
[TBL] [Abstract][Full Text] [Related]
19. QSAR models on H
Pontiki E; Hadjipavlou-Litina D
J Biomol Struct Dyn; 2017 Apr; 35(5):968-1005. PubMed ID: 26982393
[TBL] [Abstract][Full Text] [Related]
20. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment.
Chen Y; Li H; Tang W; Zhu C; Jiang Y; Zou J; Yu Q; You Q
Eur J Med Chem; 2009 Jul; 44(7):2868-76. PubMed ID: 19136179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
